S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 Tech Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 Tech Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 Tech Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 Tech Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
OTCMKTS:ORTIF

Ortho Regenerative Technologies (ORTIF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ORTIF Stock Alerts
$0.20
0.00 (0.00%)
(As of 09/9/2022)
Compare
Today's Range
$0.20
▼
$0.20
50-Day Range
$0.20
▼
$0.20
52-Week Range
$0.13
▼
$0.45
Volume
N/A
Average Volume
3,282 shs
Market Capitalization
$6.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ORTIF stock logo

About Ortho Regenerative Technologies Stock (OTCMKTS:ORTIF)

Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.

ORTIF Stock Price History

ORTIF Stock News Headlines

October 1, 2023 | proactiveinvestors.com
ChitogenX ends 2Q with stronger balance sheet as it advances its... ChitogenX ends 2Q with stronger balance sheet as it advances its...
October 1, 2023 | seekingalpha.com
Ortho Regenerative Technologies reports Q2 results
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
September 27, 2023 | wsj.com
Medprin Regenerative Medical Technologies Co. Ltd. A
August 11, 2023 | uk.investing.com
Medprin Regenerative Medical Technologies Co Ltd (301033)
April 8, 2023 | markets.businessinsider.com
ChitogenX (CHNXF) Gets a Buy from Noble Financial
April 7, 2023 | marketwatch.com
Orthopedic Regenerative Surgical Products Market Revenue, Demand Status, Top Regions and Leading Players Analysis till 2030
February 22, 2023 | marketwatch.com
Ortho Phthalic Aldehyde Market Research Report 2023 By Leading Players, Emerging Technologies, Opportunity 2029
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 11, 2023 | finance.yahoo.com
St. Vincent's Orthopedics joins Hughston Clinic's Organization
January 7, 2023 | health.usnews.com
Best Hospitals for Orthopedics
October 15, 2022 | proactiveinvestors.com
ChitogenX shares jump on launch of its second orthopedic development program in meniscus repair
September 22, 2022 | newsweek.com
Top Specialized Hospitals - Orthopedics
September 10, 2022 | finance.yahoo.com
Hope Orthopedics of Oregon Expands Hand/Wrist Service with Dr. Allison Mitchell
September 8, 2022 | seekingalpha.com
Ortho Regenerative Technologies announces name change to ChitogenX Inc.
September 7, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX
July 27, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
June 24, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS
June 13, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
May 26, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR
May 21, 2022 | seekingalpha.com
Ortho Regenerative Technologies; GAAP EPS of -C$0.14
May 20, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS
May 4, 2022 | seekingalpha.com
Ortho Regenerative gets US patent related to its soft tissue repair platform
May 4, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM
April 6, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLION
March 24, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VEST
March 21, 2022 | finance.yahoo.com
ORTHO REGENERATIVE TECHNOLOGIES AMENDS THE TERMS OF ITS $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS
See More Headlines
Receive ORTIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ortho Regenerative Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
1/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:ORTIF
CUSIP
N/A
CIK
N/A
Web
www.orthorti.com
Phone
(514) 782-0951
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,930,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-269.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.26
Quick Ratio
1.26

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.16) per share
Price / Book
-1.23

Miscellaneous

Outstanding Shares
34,956,000
Free Float
N/A
Market Cap
$6.86 million
Optionable
Not Optionable
Beta
-1.16
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Luc Mainville M.B.A (Age 58)
    M.B.A., Sr. VP & CFO
    Comp: $53.85k
  • Mr. Guy-Paul Allard
    VP of Legal Affairs & Corp. Sec.
  • Mr. Philippe Deschamps (Age 60)
    CEO, Pres & Director
  • Mr. Frederic Dumais
    Director of Communications & Investor Relations
  • Dr. Jonathan Sackier
    Chief Medical Officer
  • Benedek Simo
    Controller

Key Competitors

View All Competitors

ORTIF Stock Analysis - Frequently Asked Questions

How have ORTIF shares performed in 2024?

Ortho Regenerative Technologies' stock was trading at $0.1962 on January 1st, 2024. Since then, ORTIF stock has increased by 0.0% and is now trading at $0.1962.
View the best growth stocks for 2024 here.

How do I buy shares of Ortho Regenerative Technologies?

Shares of ORTIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ORTIF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company